The study and its comparison
Forty-six adults with generalized anxiety disorder received adjunctive theanine or placebo while continuing stable antidepressant treatment. The double-blind comparison lasted eight weeks. [1]
Anxiety reduction and overall insomnia severity did not differ significantly. One sleep-satisfaction item favored theanine, and a subgroup with less severe insomnia showed a favorable sleep result. Cognitive effects were not significant. [1]
What the finding establishes
A positive item or subgroup does not overturn a negative main comparison. The trial therefore does not establish an effective anxiety dose or justify replacing existing care. Funding and conflicts were not established from the retrieved abstract. Its results also distinguish diagnosed generalized anxiety from a brief laboratory stress response. [1]
A hypothetical distinction
Imagine one questionnaire item improves while the overall score does not. The headline should preserve the overall result.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.